Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 6 | 2020 | 745 | 0.590 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2014 | 20 | 0.530 |
Why?
|
| Tai Ji | 2 | 2014 | 28 | 0.530 |
Why?
|
| Patient Compliance | 2 | 2018 | 360 | 0.500 |
Why?
|
| Hearing Disorders | 1 | 2014 | 10 | 0.460 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 66 | 0.430 |
Why?
|
| Patient Selection | 2 | 2014 | 490 | 0.430 |
Why?
|
| Longitudinal Studies | 12 | 2020 | 1256 | 0.430 |
Why?
|
| Community Health Services | 1 | 2014 | 128 | 0.410 |
Why?
|
| Postmenopause | 1 | 2014 | 237 | 0.400 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 57 | 0.390 |
Why?
|
| Environmental Exposure | 1 | 2013 | 218 | 0.350 |
Why?
|
| Cognition | 3 | 2020 | 484 | 0.350 |
Why?
|
| Cognitive Dysfunction | 3 | 2020 | 332 | 0.330 |
Why?
|
| Hearing | 2 | 2020 | 34 | 0.300 |
Why?
|
| Desogestrel | 1 | 2008 | 4 | 0.290 |
Why?
|
| Contraceptive Agents, Female | 1 | 2008 | 24 | 0.280 |
Why?
|
| Wisconsin | 4 | 2014 | 17 | 0.270 |
Why?
|
| Olfaction Disorders | 2 | 2019 | 15 | 0.250 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2019 | 48 | 0.250 |
Why?
|
| Aged | 15 | 2020 | 14449 | 0.230 |
Why?
|
| Middle Aged | 15 | 2020 | 17615 | 0.220 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 5463 | 0.200 |
Why?
|
| Prospective Studies | 7 | 2020 | 3293 | 0.200 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2020 | 31 | 0.190 |
Why?
|
| Logistic Models | 5 | 2019 | 1276 | 0.190 |
Why?
|
| Hearing Loss | 2 | 2020 | 61 | 0.180 |
Why?
|
| Female | 17 | 2020 | 32883 | 0.180 |
Why?
|
| Quality of Life | 5 | 2019 | 1229 | 0.180 |
Why?
|
| Age Factors | 3 | 2019 | 1558 | 0.170 |
Why?
|
| Presbycusis | 1 | 2020 | 6 | 0.160 |
Why?
|
| Protective Factors | 1 | 2020 | 33 | 0.160 |
Why?
|
| Auditory Perception | 1 | 2020 | 36 | 0.160 |
Why?
|
| Cadmium | 1 | 2019 | 13 | 0.160 |
Why?
|
| Smell | 2 | 2017 | 28 | 0.160 |
Why?
|
| Adult | 13 | 2020 | 16826 | 0.150 |
Why?
|
| Auditory Threshold | 2 | 2020 | 29 | 0.150 |
Why?
|
| Vision Disorders | 1 | 2019 | 64 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 937 | 0.150 |
Why?
|
| Biomarkers | 3 | 2020 | 1408 | 0.150 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2018 | 81 | 0.150 |
Why?
|
| Male | 14 | 2020 | 29893 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2019 | 76 | 0.140 |
Why?
|
| Young Adult | 6 | 2019 | 4695 | 0.140 |
Why?
|
| Incidence | 3 | 2019 | 1377 | 0.140 |
Why?
|
| Sensation Disorders | 1 | 2017 | 21 | 0.140 |
Why?
|
| Vision, Ocular | 1 | 2017 | 20 | 0.140 |
Why?
|
| Hot Flashes | 1 | 2018 | 100 | 0.140 |
Why?
|
| Humans | 19 | 2020 | 63449 | 0.130 |
Why?
|
| Time Factors | 3 | 2020 | 3768 | 0.130 |
Why?
|
| Pancreatic Diseases | 1 | 2016 | 38 | 0.130 |
Why?
|
| Fluid Therapy | 1 | 2016 | 47 | 0.120 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2016 | 64 | 0.120 |
Why?
|
| Pancreatectomy | 1 | 2016 | 101 | 0.120 |
Why?
|
| Women's Health | 1 | 2018 | 370 | 0.120 |
Why?
|
| Menopause | 1 | 2018 | 258 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 85 | 0.120 |
Why?
|
| Least-Squares Analysis | 1 | 2014 | 24 | 0.110 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2014 | 13 | 0.110 |
Why?
|
| Risk Factors | 5 | 2019 | 5354 | 0.110 |
Why?
|
| Aspirin | 1 | 2016 | 171 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 33 | 0.110 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 49 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2014 | 61 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 205 | 0.110 |
Why?
|
| Dry Eye Syndromes | 1 | 2014 | 6 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2020 | 2570 | 0.110 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 46 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 730 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 166 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 321 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2014 | 217 | 0.100 |
Why?
|
| Demography | 1 | 2013 | 173 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 768 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 2681 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2019 | 2079 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 835 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 615 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1235 | 0.090 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 392 | 0.090 |
Why?
|
| Brain | 1 | 2019 | 1552 | 0.080 |
Why?
|
| Health Promotion | 1 | 2014 | 497 | 0.080 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2010 | 48 | 0.080 |
Why?
|
| Prevalence | 4 | 2019 | 1380 | 0.080 |
Why?
|
| United States | 6 | 2020 | 7843 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2010 | 143 | 0.070 |
Why?
|
| Contraindications | 1 | 2008 | 52 | 0.070 |
Why?
|
| Menstruation Disturbances | 1 | 2008 | 18 | 0.070 |
Why?
|
| Pregnancy, Unplanned | 1 | 2008 | 21 | 0.070 |
Why?
|
| Uterine Hemorrhage | 1 | 2008 | 20 | 0.070 |
Why?
|
| Equipment Failure | 1 | 2008 | 67 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2008 | 127 | 0.070 |
Why?
|
| Device Removal | 1 | 2008 | 68 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 1147 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 145 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2008 | 83 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2459 | 0.070 |
Why?
|
| Twins, Dizygotic | 1 | 2007 | 55 | 0.070 |
Why?
|
| Nurse's Role | 1 | 2008 | 120 | 0.070 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 70 | 0.070 |
Why?
|
| Nurse Practitioners | 1 | 2008 | 117 | 0.070 |
Why?
|
| Weight Gain | 1 | 2008 | 169 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 352 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 210 | 0.060 |
Why?
|
| Counseling | 1 | 2008 | 362 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1173 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 475 | 0.060 |
Why?
|
| Asthma | 1 | 2007 | 459 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 397 | 0.050 |
Why?
|
| Sex Factors | 2 | 2019 | 978 | 0.050 |
Why?
|
| Dementia | 2 | 2016 | 260 | 0.050 |
Why?
|
| Aldosterone | 1 | 2020 | 18 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2020 | 34 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2020 | 35 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 85 | 0.040 |
Why?
|
| Lead | 1 | 2019 | 43 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 19 | 0.040 |
Why?
|
| Veterans | 1 | 2007 | 765 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2019 | 53 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 61 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 265 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 583 | 0.040 |
Why?
|
| Vitamin D | 1 | 2019 | 140 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 177 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2017 | 145 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2016 | 14 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 127 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1120 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1553 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 253 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 258 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2014 | 125 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 216 | 0.020 |
Why?
|
| Olfactory Perception | 1 | 2011 | 3 | 0.020 |
Why?
|
| Nasal Polyps | 1 | 2011 | 10 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 13 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 291 | 0.020 |
Why?
|
| Self Report | 1 | 2014 | 375 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 436 | 0.020 |
Why?
|
| Income | 1 | 2011 | 169 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 35 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 76 | 0.020 |
Why?
|
| Posture | 1 | 2010 | 127 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 134 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2010 | 104 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 134 | 0.020 |
Why?
|
| Movement | 1 | 2010 | 156 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 270 | 0.020 |
Why?
|
| Gait | 1 | 2010 | 119 | 0.020 |
Why?
|
| Schools | 1 | 2010 | 166 | 0.020 |
Why?
|
| Vietnam Conflict | 1 | 2007 | 26 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6659 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 574 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5680 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1119 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 888 | 0.010 |
Why?
|